MiMedx Group
MDXG
Operating Margin for MiMedx Group (MDXG)
Operating Margin as of May 2024 (TTM): -8.72%
According to MiMedx Group's latest financial reports and stock price the company's current Operating Margin is -8.72%. At the end of 2022 the company had an Operating Margin of -9.32%.
Operating Margin history for MiMedx Group from 2010 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -9.32% | 376.76% |
| 2021 | -1.96% | -90.94% |
| 2020 | -21.59% | 211.96% |
| 2019 | -6.92% | 533.46% |
| 2018 | -1.09% | -107.59% |
| 2017 | 14.39% | 91.19% |
| 2016 | 7.53% | -42.13% |
| 2015 | 13.01% | 116.6% |
| 2014 | 6.01% | -234.7% |
| 2013 | -4.46% | -77.48% |
| 2012 | -19.80% | -84.26% |
| 2011 | -125.78% | -90.83% |
| 2010 | -1,371.59% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Medtronic MDT | 17.17% | -296.90% | 🇮🇪 Ireland |
 Teleflex TFX | 15.97% | -283.14% | 🇺🇸 USA |
 Steris STE | 3.54% | -140.60% | 🇮🇪 Ireland |
 NuVasive NUVA | 4.35% | -149.89% | 🇺🇸 USA |
 Hill-Rom HRC | 12.20% | -239.95% | 🇺🇸 USA |
 CryoLife CRY | 0.69% | -107.91% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.